4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-045904
Chairman and CEO bought 3,900 shares at an average $1.53 ($5,958)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2021-07-02 | Purchase | +1,600 | $1.51 | $2,416 | 10,781,271 | D |
| Niihara Yutaka Chairman and CEO | 2021-07-06 | Purchase | +800 | $1.54 | $1,232 | 10,782,071 | D |
| Niihara Yutaka Chairman and CEO | 2021-07-07 | Purchase | +1,500 | $1.54 | $2,310 | 10,783,571 | D |
| Open-market purchases · 3,900 sh · avg $1.53 · $5,958 | |||||||
Loading xslF345X03/doc4.xml…